Change in Adiponectin – Metabolic Syndrome Clinical Study

• Overview (study design, subjects background, etc.) – metabolic syndrome clinical study

Therapeutic intervention for Group C: standard-of-care
Therapeutic intervention for Group R: standard-of-care and RE therapy

After four weeks and eight weeks of therapy, the blood adiponectin levels in Group R were statistically significantly lower than those in Group C.

From these, adding RE therapy to the standard-of-care was inferred to be effective in improving blood adiponectin levels.